Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Desmopressin in Previously Untreated Children With Primary Nocturnal Enuresis
NCT00245479Phase 4Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Apr 2002
- Primary completion
- Sep 2005
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of desmopressin in nocturnal enuresis (NE), sponsored by Ferring Pharmaceuticals. Primary endpoint: Overall response to desmopressin treatment at 6 months. Started Apr 2002; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT00245479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245479.